Close Menu

NEW YORK (GenomeWeb) – NanoString said today that life science reagents firm Abcam will provide antibodies for use with its GeoMx Digital Spatial Profiler (DSP) platform, which the company launched this week at the American Association for Cancer Research annual meeting.

Under the agreement, Abcam will create custom panels for the GeoMx DSP platform from its collection of 6,000-plus recombinant monoclonal antibodies, which have been validated for use in fresh frozen and formalin-fixed paraffin-embedded tissue.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.